BXP
60
5
VMC
60
-2
NVDA
54
2
HCP
62
-8
ADBE
61
11
KO
47
-2
ED
55
3
LEG
43
-7
F
54
-6
RL
80
2
OXY
37
-3
COP
47
2
HSIC
60
-2
SWK
67
-4
STZ
52
-5
NKE
39
-3
MPC
44
3
PSA
63
2
ETR
72
3
LYB
41
-2
BXP
60
5
VMC
60
-2
NVDA
54
2
HCP
62
-8
ADBE
61
11
KO
47
-2
ED
55
3
LEG
43
-7
F
54
-6
RL
80
2
OXY
37
-3
COP
47
2
HSIC
60
-2
SWK
67
-4
STZ
52
-5
NKE
39
-3
MPC
44
3
PSA
63
2
ETR
72
3
LYB
41
-2
Financhill
Back

Biodexa Pharmaceuticals PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
20

BDRX
Biodexa Pharmaceuticals PLC

Last Price:
4.80
Seasonality Move:
-23.1%
Sell
27

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.70
Seasonality Move:
53.66%
Sell
20
Biodexa Pharmaceuticals PLC (BDRX) is a Sell

Is Biodexa Pharmaceuticals PLC a Buy, Sell or Hold?

  • The current Biodexa Pharmaceuticals PLC [BDRX] share price is $4.80. The Score for BDRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • BDRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
27
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.68. The Score for ADAP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BDRX Stock Price Chart

What is Biodexa Pharmaceuticals PLC's stock price today?

  • The Biodexa Pharmaceuticals PLC share price today is $4.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BDRX is experiencing slight buying pressure.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.

BDRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 44.69 Sell
Chaikin Money Flow: 2455 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.32 - 6.3) Sell
Bollinger Bands (100): (-0.01 - 4.89) Buy

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 42.73 Sell
Chaikin Money Flow: -263450 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.66 - 0.8) Sell
Bollinger Bands (100): (0.79 - 1.21) Sell

BDRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.18 Buy
20-day SMA: 4.98 Sell
50-day SMA: 4.22 Buy
200-day SMA: 1.78 Buy
8-day EMA: 4.56 Buy
20-day EMA: 4.76 Buy
50-day EMA: 4.18 Buy
200-day EMA: 11.99 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.65 Buy
20-day SMA: 0.72 Sell
50-day SMA: 0.82 Sell
200-day SMA: 1.11 Sell
8-day EMA: 0.68 Buy
20-day EMA: 0.71 Sell
50-day EMA: 0.82 Sell
200-day EMA: 0.99 Sell

Biodexa Pharmaceuticals PLC Earnings Growth & BDRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.

Biodexa Pharmaceuticals PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):